Noah Holdings Limited (09969) directors and executives plan to reduce their shareholding.

Wisdom Financial News APP reported that Nuocheng Jianhua (09969) announced that the company recently received a notice from executive director, chairman of the board, and CEO Jisong Cui, executive director and senior vice president of hematology medical research and clinical development Renbin Zhao, and chief technology officer Xiangyang Chen regarding their share reduction plan. Due to personal financial needs, Jisong Cui, Renbin Zhao, and Xiangyang Chen plan to reduce their directly held company A shares from July 16, 2026 to September 30, 2026.